Covidien touts FDA clearance for its novel camera-equipped Kangaroo feeding tube designed to provide visualization for an otherwise blind procedure.
Medtech titan Covidien (NYSE:COV) received FDA clearance for its visual Kangaroo feeding tube, equipped with an endoscopic camera that allows physicians to see into the procedure in a new way.
Philips voluntarily suspends manufacturing at an Ohio facility after an FDA investigation turns up "certain issues in the general area of manufacturing process controls."
Philips Healthcare (NYSE:PHG) halted work at an Ohio manufacturing facility after an FDA inspection turned up some concerns with process controls, a company spokesman confirmed with MassDevice.com today.
Sales and profits were down during the 1st quarter for GE Healthcare, which cited "market volatility" for the declines.
keys: ge healthcare, general electric, earnings
GE Healthcare (NYSE:GE) saw its sales and profits decline by single digits during the 1st quarter due to "market volatility.
FDA regulators GE Healthcare's latest high-def, low-dose CT scanner, which the company calls the 1st that's "right for physicians in every clinical specialty."
GE Healthcare's (NYSE:GE) this week touted a new FDA win for its latest in CT scanner technology, saying the Revolution* CT^ is the 1st of its kind that's right for "every clinical specialty."
Analogic says it won 510(k) clearance from the FDA for its Sonic Window, a handheld ultrasound device for visualizing the vasculature for peripheral IV access.
Analogic (NSDQ:ALOG) said it won 510(k) clearance from the FDA for its handheld Sonic Window ultrasound device, designed to help caregivers view the vasculature to guide peripheral IV placement.
Technology giant GE Healthcare lands U.S. regulatory clearance for its Q.Clear medical image reconstruction technology.
GE Healthcare's (NYSE:GE) won FDA clearance for its latest image reconstruction technology, the Q.Clear system for use with PET/CT scanning.
Medtronic says it won CE Mark approval in the European Union for its Evera MRI SureScan implantable cardiac defibrillator, claiming it as the world's 1st ICD approved for full-body magnetic resonance imaging scans.
Medtronic (NYSE:MDT) said it won CE Mark approval in the European Union for the world's 1st market-cleared implantable cardiac defibrillator that's safe for full-body magnetic resonance imaging scans, its Evera MRI SureScan ICD.
The Evera device is slated for an immediate launch in Europe, according to a press release.